Fingolimod for multiple sclerosis
D Pelletier, DA Hafler - New England Journal of Medicine, 2012 - Mass Medical Soc
New England Journal of Medicine, 2012•Mass Medical Soc
A 37-year-old man with multiple sclerosis has recurrent disease activity despite several
previous therapies. Treatment with fingolimod is recommended. Fingolimod blocks the
egress of lymphocytes from lymph nodes, preventing them from reaching the central nervous
system.
previous therapies. Treatment with fingolimod is recommended. Fingolimod blocks the
egress of lymphocytes from lymph nodes, preventing them from reaching the central nervous
system.
A 37-year-old man with multiple sclerosis has recurrent disease activity despite several previous therapies. Treatment with fingolimod is recommended. Fingolimod blocks the egress of lymphocytes from lymph nodes, preventing them from reaching the central nervous system.
The New England Journal Of Medicine